Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

307 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 307 results

Testing effectiveness (Phase 2)UnknownNCT04202978
What this trial is testing

Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer

Who this might be right for
Hepatic Metastasis of Colorectal Cancer
Zhongshan Hospital Xiamen University 23
Testing effectiveness (Phase 2)UnknownNCT06482008
What this trial is testing

HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 33
Large-scale testing (Phase 3)Study completedNCT03764293
What this trial is testing

Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC

Who this might be right for
Locally Advanced or Metastatic and Unresectable HCC
Jiangsu HengRui Medicine Co., Ltd. 543
Testing effectiveness (Phase 2)UnknownNCT03193424
What this trial is testing

Apatinib Combined With Docetaxel in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Advanced Esophageal Squamous Carcinoma
The First Affiliated Hospital of Zhengzhou University 120
Very early researchUnknownNCT04074564
What this trial is testing

MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma

Who this might be right for
Sarcoma
HRYZ Biotech Co. 60
Testing effectiveness (Phase 2)UnknownNCT04722718
What this trial is testing

Efficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast Cancer

Who this might be right for
Breast Cancer
Jiuda Zhao 34
Testing effectiveness (Phase 2)UnknownNCT04068974
What this trial is testing

Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer

Who this might be right for
Recurrent Platinum-resistant Ovarian Cancer
Peking Union Medical College Hospital 28
Testing effectiveness (Phase 2)Study completedNCT05156970
What this trial is testing

Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 81
Testing effectiveness (Phase 2)UnknownNCT02943252
What this trial is testing

The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Temporarily pausedNCT04824352
What this trial is testing

Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma

Who this might be right for
Effect of DrugToxicity, Drug
Peking University People's Hospital 44
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06773156
What this trial is testing

Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Second Affiliated Hospital of Nanchang University 37
Large-scale testing (Phase 3)UnknownNCT04968002
What this trial is testing

Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy

Who this might be right for
Non-small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Testing effectiveness (Phase 2)UnknownNCT04318730
What this trial is testing

Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
West China Hospital 21
Testing effectiveness (Phase 2)UnknownNCT03801200
What this trial is testing

Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC

Who this might be right for
NSCLC
Hubei Cancer Hospital 90
Testing effectiveness (Phase 2)UnknownNCT05265793
What this trial is testing

Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma

Who this might be right for
PD-1 ImmunotherapyVEGFR-TKISarcomatoid Carcinoma+1 more
Fudan University 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07773363
What this trial is testing

Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tang-Du Hospital 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07682272
What this trial is testing

A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma

Who this might be right for
Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06771154
What this trial is testing

Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial

Who this might be right for
Recurrent/Metastatic Endometrial Cancer
Peking Union Medical College Hospital 140
Testing effectiveness (Phase 2)Study completedNCT03129256
What this trial is testing

An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Changzhou Cancer Hospital of Soochow University 52
Large-scale testing (Phase 3)UnknownNCT02875457
What this trial is testing

Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin

Who this might be right for
Small Cell Lung Cancer
Third Military Medical University 100
Next Page